A Study of Bumetanide for the Treatment of Autism Spectrum Disorders
Status:
Completed
Trial end date:
2019-07-10
Target enrollment:
Participant gender:
Summary
The investigators are going to carry out a randomized double-blind placebo-controlled trial
to study the efficiency and mechanism of bumetanide on the treatment of children with Autism
Spectrum Disorder.
Phase:
Phase 2
Details
Lead Sponsor:
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine